CER Daily Newsfeed

Real-World Data Shows Novo Nordisk’s Semaglutide Outperforms Eli Lilly’s Tirzepatide on Cardiovascular Outcomes

(9/4, Katie McCool, The Evidence Base) reports “...Novo Nordisk has reported that Wegovy reduced the risk of heart attack, stroke, or death by 57% compared with tirzepatide in patients with obesity and cardiovascular disease, based on findings from the STEER real-world study. The analysis examined health insurance claims from more than 21,000 US patients in the Komodo Research database who began treatment with either drug from May 2022. After propensity score matching, 10,625 people were included in each group, all aged 45 years or older with overweight or obesity and established cardiovascular disease, but no diabetes.” Full

PhRMA Launches Ad Campaign Urging Congress to Address '340B Medicine Mark-Ups'

(9/3, Dave Muoio, Fierce Healthcare) reports “...The Pharmaceutical Research and Manufacturers of America's (PhRMA's) campaign, called ‘Meet Mark,’ targets the Washington, D.C., market with a combination of videos and other materials running on television, digital and social media platforms. The seven-figure campaign is set to run through the end of the year, the group told Fierce Healthcare. ‘When hospitals have free rein to mark up medicines, everyone pays the price,’ PhRMA wrote in a release outlining the campaign. ‘It is time to stop tax-exempt hospitals from rampantly abusing the program and ensure that the program benefits low-income patients by lowering their medicine costs.’” Full

Australian Govt To Start HTA System Overhaul – One Year After Major Review

(9/4, Eliza Slawther, Pink Sheet) reports “...The Australian government says it is taking ‘immediate actions’ to overhaul its health technology assessment system. This will include updating guidelines around using the lowest cost comparator drug in HTAs, a practice that industry has long opposed.” Subscription Required

Kuwait Advances Evidence-Based Healthcare with New HTA Roadmap

(9/4, Arab Times) reports “Kuwait’s Ministry of Health on Wednesday held a workshop title ‘Drawing a Roadmap to Activate the Health Technology Assessment (HTA) System’ under the patronage and attendance of Minister of Health Dr. Ahmad Al-Awadhi, with participation from ministry leaders, academic partners, and international organizations.” Full